Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Active, Not Recruiting
Checked: September 1, 2026 at 4:49 PM UTC
| NCT Number | NCT06448754 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Non-small Cell Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 180 participants |
| Active Locations | 7 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | August 31, 2026 (Yesterday) |
As of September 1, 2026: Clinical trial NCT06448754 is currently active_not_recruiting participants. This phase2 study for non-small cell lung cancer is not currently accepting new participants at 7 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06448754 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06448754 was last updated Yesterday (August 31, 2026). HelloStudys verifies this status automatically.